跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71,638 条关于
“B-cell Lymphomas”
全部
71,638
临床试验
48,117
药物
6,447
机构
3,220
资讯
13,854
2年前
Roche's Glofitamab Expands Treatment Horizons for Multiple B-Cell Lymphomas
3年前
FDA Approves Two Bispecific T-Cell Engagers for Relapsed/Refractory B-Cell Lymphomas
去年
Subcutaneous Mosunetuzumab Shows Promise in Untreated B-Cell Lymphomas with Durable Responses
去年
Study Links Long-term Tattoo Exposure to Increased Risk of Rare B-Cell Lymphomas
去年
ImmuneOnco's CD47xCD20 Bispecific IMM0306 Advances to Phase II with Promising Efficacy in B-Cell Lymphomas
去年
Recursion Doses First Patient in Phase 1 Trial of REC-3565 for Relapsed B-cell Lymphomas
3年前
Genmab and AbbVie Submit Regulatory Applications for Epcoritamab Bispecific Antibody in Relapsed/Refractory B-Cell Lymphomas
去年
Immunome Initiates Phase 1 Trial of ROR1-Targeted ADC for B-Cell Lymphomas and Solid Tumors
3个月前
Tafasitamab-Lenalidomide Combination Reduces Disease Progression Risk by 25% in High-Risk Aggressive B-Cell Lymphomas
10天前
PeproMene Bio's BAFF-R CAR T-Cell Therapy Shows 80% Complete Response Rate in Relapsed/Refractory B-Cell Lymphomas
第 1 页,共 1386 页
上一页
下一页